Neuphoria Therapeutics
Price & Volume
Stats
See more52W Range | $3.03-$5.53 |
Market Cap | $16.5M |
Shares Short | 6,429 |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $1.1M |
Diluted EPS | -$3.06 |
News
See moreYahoo Finance • 3 months ago
The M&A Class Action Firm Encourages $hareholders To Contact Monteverde Concerning The Merger—NRIM, NEUP, SAFT, and RMAX
Yahoo Finance • 4 months ago
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Yahoo Finance • 11 months ago
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions
Yahoo Finance • 11 months ago
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
About
CEO | Dr. Spyridon Papapetropoulos M.D., Ph.D. |
CFO | Mr. Timothy M. Cunningham CPA, M.B.A. |
Address | 14 Milliston Road, Millis, MA, United States, 02054 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1 |